AI drug discovery pact: Why drugmakers can’t ignore Merck Mayo
Merck’s new partnership with Mayo Clinic wires hospital-grade clinical data into drug-discovery AI, promising faster target validation and efficiency gains — while concentrating power, driving up costs, and raising privacy and reproducibility questions. Read how platformized data plus institutional compute could reshape pharma, winners, losers, and the invoice for innovation.
